More articles from Minireview

You have access
Targets of Neuroprotection and Review of Pharmacological Interventions in Traumatic Brain Injury
Matthew I. Hiskens

Journal of Pharmacology and Experimental Therapeutics August 2022, 382 (2) 149-166; DOI: https://doi.org/10.1124/jpet.121.001023
You have access
Therapeutic Basis of Generic Substitution of Antiseizure Medications
Sarah Elmer and Doodipala Samba Reddy

Journal of Pharmacology and Experimental Therapeutics May 2022, 381 (2) 188-196; DOI: https://doi.org/10.1124/jpet.121.000994
You have access
Therapeutic Approaches to Nociplastic Pain Based on Findings in the Reserpine-Induced Fibromyalgia-Like Animal Model
Yukinori Nagakura

Journal of Pharmacology and Experimental Therapeutics May 2022, 381 (2) 106-119; DOI: https://doi.org/10.1124/jpet.121.001051
You have access
Attenuation of Response to Repeated Drug Administration: A Proposal for Differentiating Tachyphylaxis and Tolerance
Craig K. Svensson

Journal of Pharmacology and Experimental Therapeutics April 2022, 381 (1) 22-32; DOI: https://doi.org/10.1124/jpet.121.000978
You have access
The Role of Ruthenium Compounds in Neurologic Diseases: A Minireview
Fátima Virgínia Gama Justi, Gabriella Araújo Matos, Juan de Sá Roriz Caminha, Cássia Rodrigues Roque, Edinilton Muniz Carvalho, Márcio Wilker Soares Campelo, Ludmila Belayev, Luiz Gonzaga de França Lopes and Reinaldo Barreto Oriá

Journal of Pharmacology and Experimental Therapeutics January 2022, 380 (1) 47-53; DOI: https://doi.org/10.1124/jpet.121.000798
You have access
Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity
Douglas R. Miller, Mengfei Bu, Adithya Gopinath, Luis R. Martinez and Habibeh Khoshbouei

Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 372-385; DOI: https://doi.org/10.1124/jpet.121.000767
You have access
5-Aza-4′-thio-2′-deoxycytidine, a New Orally Bioavailable Nontoxic “Best-in-Class”: DNA Methyltransferase 1–Depleting Agent in Clinical Development
William B. Parker and Jaideep V. Thottassery

Journal of Pharmacology and Experimental Therapeutics December 2021, 379 (3) 211-222; DOI: https://doi.org/10.1124/jpet.121.000758
You have access
The Soluble (Pro)Renin Receptor in Health and Diseases: Foe or Friend?
Manman Qin, Chuanming Xu and Jun Yu

Journal of Pharmacology and Experimental Therapeutics September 2021, 378 (3) 251-261; DOI: https://doi.org/10.1124/jpet.121.000576
Open Access
Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development
Wei Zhu, Zeenat Shyr, Donald C. Lo and Wei Zheng

Journal of Pharmacology and Experimental Therapeutics August 2021, 378 (2) 166-172; DOI: https://doi.org/10.1124/jpet.121.000688
Open Access
Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling
Zizhen Si and Xidi Wang

Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 207-217; DOI: https://doi.org/10.1124/jpet.120.000324

Main menu

User menu

Search

More articles from Minireview

Pages

Navigate

More Information

ASPET's Other Journals